

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | neutrophil activation involved in immune response (GO:0002283) | 7.90400040 |
| 2 | thrombin receptor signaling pathway (GO:0070493) | 6.57462231 |
| 3 | regulation of platelet aggregation (GO:0090330) | 6.07987499 |
| 4 | regulation of platelet activation (GO:0010543) | 5.48453478 |
| 5 | blood coagulation, intrinsic pathway (GO:0007597) | 5.43567692 |
| 6 | adenosine receptor signaling pathway (GO:0001973) | 5.36445001 |
| 7 | leukocyte migration involved in inflammatory response (GO:0002523) | 5.34530669 |
| 8 | chaperone-mediated protein transport (GO:0072321) | 5.06282620 |
| 9 | platelet aggregation (GO:0070527) | 4.96824963 |
| 10 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 4.95098688 |
| 11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.87062274 |
| 12 | positive regulation of mast cell activation (GO:0033005) | 4.86802194 |
| 13 | neutrophil activation (GO:0042119) | 4.82961810 |
| 14 | lipoxygenase pathway (GO:0019372) | 4.81983441 |
| 15 | positive regulation of endothelial cell differentiation (GO:0045603) | 4.69195929 |
| 16 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.64401619 |
| 17 | termination of RNA polymerase III transcription (GO:0006386) | 4.64401619 |
| 18 | long-chain fatty acid biosynthetic process (GO:0042759) | 4.60060211 |
| 19 | negative regulation of platelet activation (GO:0010544) | 4.51154134 |
| 20 | granulocyte activation (GO:0036230) | 4.36608228 |
| 21 | axon ensheathment in central nervous system (GO:0032291) | 4.28757505 |
| 22 | central nervous system myelination (GO:0022010) | 4.28757505 |
| 23 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 4.24391459 |
| 24 | angiogenesis involved in wound healing (GO:0060055) | 4.22176707 |
| 25 | negative regulation of norepinephrine secretion (GO:0010700) | 4.16348476 |
| 26 | ribosomal small subunit assembly (GO:0000028) | 4.16160832 |
| 27 | positive regulation of macrophage differentiation (GO:0045651) | 4.13281374 |
| 28 | regulation of integrin-mediated signaling pathway (GO:2001044) | 4.09693387 |
| 29 | ribosomal small subunit biogenesis (GO:0042274) | 4.09102859 |
| 30 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 4.05937879 |
| 31 | negative regulation of heart rate (GO:0010459) | 4.04288070 |
| 32 | polyamine biosynthetic process (GO:0006596) | 4.00248758 |
| 33 | proteasome assembly (GO:0043248) | 3.97042439 |
| 34 | ribosomal large subunit biogenesis (GO:0042273) | 3.94846232 |
| 35 | low-density lipoprotein particle remodeling (GO:0034374) | 3.92670165 |
| 36 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 3.85116533 |
| 37 | positive regulation of protein homodimerization activity (GO:0090073) | 3.81530062 |
| 38 | positive regulation of cAMP-mediated signaling (GO:0043950) | 3.78054983 |
| 39 | regulation of integrin activation (GO:0033623) | 3.76160074 |
| 40 | platelet degranulation (GO:0002576) | 3.70940479 |
| 41 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 3.70598462 |
| 42 | GPI anchor biosynthetic process (GO:0006506) | 3.69816042 |
| 43 | regulation of MHC class II biosynthetic process (GO:0045346) | 3.67739651 |
| 44 | regulation of homotypic cell-cell adhesion (GO:0034110) | 3.66095121 |
| 45 | megakaryocyte development (GO:0035855) | 3.66025449 |
| 46 | 7-methylguanosine mRNA capping (GO:0006370) | 3.63479600 |
| 47 | homotypic cell-cell adhesion (GO:0034109) | 3.62353667 |
| 48 | platelet activation (GO:0030168) | 3.59625835 |
| 49 | regulation of mast cell degranulation (GO:0043304) | 3.58711360 |
| 50 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.58309675 |
| 51 | purinergic receptor signaling pathway (GO:0035587) | 3.55769358 |
| 52 | RNA capping (GO:0036260) | 3.54595692 |
| 53 | 7-methylguanosine RNA capping (GO:0009452) | 3.54595692 |
| 54 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 3.54109111 |
| 55 | positive regulation of granulocyte differentiation (GO:0030854) | 3.53206192 |
| 56 | preassembly of GPI anchor in ER membrane (GO:0016254) | 3.48044959 |
| 57 | platelet formation (GO:0030220) | 3.46664400 |
| 58 | leukocyte degranulation (GO:0043299) | 3.45652703 |
| 59 | regulation of mast cell activation (GO:0033003) | 3.43151334 |
| 60 | positive regulation of mast cell degranulation (GO:0043306) | 3.42550447 |
| 61 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.42550447 |
| 62 | positive regulation of receptor recycling (GO:0001921) | 3.41823735 |
| 63 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.38874888 |
| 64 | positive regulation of systemic arterial blood pressure (GO:0003084) | 3.38181030 |
| 65 | GPI anchor metabolic process (GO:0006505) | 3.32330284 |
| 66 | fusion of sperm to egg plasma membrane (GO:0007342) | 3.29867305 |
| 67 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 3.28716794 |
| 68 | positive regulation of Rho protein signal transduction (GO:0035025) | 3.27720628 |
| 69 | peptidyl-histidine modification (GO:0018202) | 3.26711479 |
| 70 | termination of RNA polymerase I transcription (GO:0006363) | 3.23662259 |
| 71 | transcription from RNA polymerase I promoter (GO:0006360) | 3.22246668 |
| 72 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.20848190 |
| 73 | negative regulation of appetite (GO:0032099) | 3.19666454 |
| 74 | negative regulation of response to food (GO:0032096) | 3.19666454 |
| 75 | protein neddylation (GO:0045116) | 3.19662524 |
| 76 | maturation of 5.8S rRNA (GO:0000460) | 3.15304610 |
| 77 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.15187212 |
| 78 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.14242153 |
| 79 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 3.11304105 |
| 80 | maturation of SSU-rRNA (GO:0030490) | 3.10676904 |
| 81 | DNA deamination (GO:0045006) | 3.08900323 |
| 82 | transcription elongation from RNA polymerase I promoter (GO:0006362) | 3.08883087 |
| 83 | viral transcription (GO:0019083) | 3.08592528 |
| 84 | mannosylation (GO:0097502) | 3.08582686 |
| 85 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.06284920 |
| 86 | regulation of endothelial cell differentiation (GO:0045601) | 3.06043277 |
| 87 | negative regulation of neural precursor cell proliferation (GO:2000178) | 3.05641610 |
| 88 | regulation of lipoprotein metabolic process (GO:0050746) | 3.05025268 |
| 89 | myeloid cell activation involved in immune response (GO:0002275) | 3.04991420 |
| 90 | DNA ligation (GO:0006266) | 3.04757557 |
| 91 | keratinocyte development (GO:0003334) | 3.04008070 |
| 92 | regulation of cholesterol efflux (GO:0010874) | 3.03316273 |
| 93 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 3.03034302 |
| 94 | positive regulation of hemostasis (GO:1900048) | 3.02866992 |
| 95 | positive regulation of blood coagulation (GO:0030194) | 3.02866992 |
| 96 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 3.00901273 |
| 97 | termination of signal transduction (GO:0023021) | 2.99858967 |
| 98 | regulation of nuclear cell cycle DNA replication (GO:0033262) | 2.99827194 |
| 99 | regulation of Golgi to plasma membrane protein transport (GO:0042996) | 2.99650371 |
| 100 | regulation of norepinephrine secretion (GO:0014061) | 2.99484835 |
| 101 | beta-amyloid metabolic process (GO:0050435) | 2.97958214 |
| 102 | phagocytosis, engulfment (GO:0006911) | 2.96497222 |
| 103 | protein K6-linked ubiquitination (GO:0085020) | 2.95932857 |
| 104 | fatty acid elongation (GO:0030497) | 2.95197088 |
| 105 | isoprenoid biosynthetic process (GO:0008299) | 2.95080020 |
| 106 | termination of G-protein coupled receptor signaling pathway (GO:0038032) | 2.94633019 |
| 107 | translational termination (GO:0006415) | 2.94245275 |
| 108 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.93007172 |
| 109 | pyrimidine nucleoside catabolic process (GO:0046135) | 2.91372352 |
| 110 | extracellular fibril organization (GO:0043206) | 2.89684192 |
| 111 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.89372089 |
| 112 | superoxide anion generation (GO:0042554) | 2.89263627 |
| 113 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.88798388 |
| 114 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 2.88498120 |
| 115 | histone H2B ubiquitination (GO:0033523) | 2.88136238 |
| 116 | autophagic vacuole fusion (GO:0000046) | 2.88118658 |
| 117 | presynaptic membrane assembly (GO:0097105) | 2.87214466 |
| 118 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.86136030 |
| 119 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.86089154 |
| 120 | mitochondrial calcium ion transport (GO:0006851) | 2.84286439 |
| 121 | cytochrome complex assembly (GO:0017004) | 2.84042852 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371) | 2.83613616 |
| 123 | negative regulation of T-helper cell differentiation (GO:0045623) | 2.83613616 |
| 124 | microtubule polymerization or depolymerization (GO:0031109) | 2.83132416 |
| 125 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 2.83037259 |
| 126 | cellular biogenic amine biosynthetic process (GO:0042401) | 2.82039053 |
| 127 | transcription initiation from RNA polymerase I promoter (GO:0006361) | 2.81298532 |
| 128 | tRNA methylation (GO:0030488) | 2.79729445 |
| 129 | negative regulation of heart contraction (GO:0045822) | 2.79681629 |
| 130 | DNA damage response, detection of DNA damage (GO:0042769) | 2.78717329 |
| 131 | regulation of leukocyte degranulation (GO:0043300) | 2.78634543 |
| 132 | positive regulation of B cell mediated immunity (GO:0002714) | 2.78061343 |
| 133 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 2.78061343 |
| 134 | negative regulation of cell killing (GO:0031342) | 2.77175134 |
| 135 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.77175134 |
| 136 | negative regulation of protein localization to cell surface (GO:2000009) | 2.75805140 |
| 137 | cyclooxygenase pathway (GO:0019371) | 2.75293881 |
| 138 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.74832978 |
| 139 | presynaptic membrane organization (GO:0097090) | 2.73428625 |
| 140 | high-density lipoprotein particle remodeling (GO:0034375) | 2.72838221 |
| 141 | rRNA modification (GO:0000154) | 2.72774375 |
| 142 | positive regulation of coagulation (GO:0050820) | 2.72609642 |
| 143 | microglial cell activation (GO:0001774) | 2.72220023 |
| 144 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.72060282 |
| 145 | peptide catabolic process (GO:0043171) | 2.71985794 |
| 146 | microtubule depolymerization (GO:0007019) | 2.71828944 |
| 147 | phospholipid homeostasis (GO:0055091) | 2.71582092 |
| 148 | centriole assembly (GO:0098534) | 2.71424902 |
| 149 | respiratory chain complex IV assembly (GO:0008535) | 2.71252529 |
| 150 | regulation of mitochondrial translation (GO:0070129) | 2.70485347 |
| 151 | cotranslational protein targeting to membrane (GO:0006613) | 2.69638141 |
| 152 | negative regulation of chemokine production (GO:0032682) | 2.68933715 |
| 153 | membrane invagination (GO:0010324) | 2.68810416 |
| 154 | negative regulation of stress fiber assembly (GO:0051497) | 2.68605507 |
| 155 | vesicle targeting (GO:0006903) | 2.68098226 |
| 156 | protein targeting to mitochondrion (GO:0006626) | 2.67855954 |
| 157 | regulation of receptor recycling (GO:0001919) | 2.67606777 |
| 158 | centriole replication (GO:0007099) | 2.66269012 |
| 159 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 2.65846517 |
| 160 | protein targeting to ER (GO:0045047) | 2.62853035 |
| 161 | protein localization to endoplasmic reticulum (GO:0070972) | 2.62753589 |
| 162 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.61986682 |
| 163 | V(D)J recombination (GO:0033151) | 2.60842567 |
| 164 | metallo-sulfur cluster assembly (GO:0031163) | 2.59758001 |
| 165 | iron-sulfur cluster assembly (GO:0016226) | 2.59758001 |
| 166 | deoxyribonucleoside diphosphate metabolic process (GO:0009186) | 2.58697813 |
| 167 | protein complex biogenesis (GO:0070271) | 2.58663371 |
| 168 | cellular component biogenesis (GO:0044085) | 2.58635589 |
| 169 | energy homeostasis (GO:0097009) | 2.56660676 |
| 170 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.55526992 |
| 171 | CENP-A containing nucleosome assembly (GO:0034080) | 2.54551677 |
| 172 | C-terminal protein lipidation (GO:0006501) | 2.53930362 |
| 173 | regulation of development, heterochronic (GO:0040034) | 2.53122704 |
| 174 | regulation of timing of cell differentiation (GO:0048505) | 2.51922100 |
| 175 | DNA replication checkpoint (GO:0000076) | 2.51612881 |
| 176 | oligodendrocyte differentiation (GO:0048709) | 2.51298701 |
| 177 | positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968) | 2.50551944 |
| 178 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.49305559 |
| 179 | DNA integration (GO:0015074) | 2.49132028 |
| 180 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.48356231 |
| 181 | telomere maintenance via recombination (GO:0000722) | 2.47592774 |
| 182 | establishment of protein localization to mitochondrion (GO:0072655) | 2.46622454 |
| 183 | positive regulation of viral transcription (GO:0050434) | 2.45315492 |
| 184 | negative regulation of myoblast differentiation (GO:0045662) | 2.44705121 |
| 185 | establishment of integrated proviral latency (GO:0075713) | 2.42667547 |
| 186 | cellular protein complex disassembly (GO:0043624) | 2.41740568 |
| 187 | spliceosomal complex assembly (GO:0000245) | 2.40054830 |
| 188 | translation (GO:0006412) | 2.39879304 |
| 189 | rRNA processing (GO:0006364) | 2.39054285 |
| 190 | negative regulation of transcription by competitive promoter binding (GO:0010944) | 2.38399589 |
| 191 | chromatin remodeling at centromere (GO:0031055) | 2.38140789 |
| 192 | negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254) | 2.38063704 |
| 193 | DNA-templated transcription, elongation (GO:0006354) | 2.37495864 |
| 194 | dendritic cell chemotaxis (GO:0002407) | 2.37169188 |
| 195 | GMP metabolic process (GO:0046037) | 2.36805372 |
| 196 | DNA-templated transcription, termination (GO:0006353) | 2.36800408 |
| 197 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.35702738 |
| 198 | viral mRNA export from host cell nucleus (GO:0046784) | 2.35606834 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 5.23868159 |
| 2 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 4.44634450 |
| 3 | SCL_19346495_ChIP-Seq_HPC-7_Human | 4.29506973 |
| 4 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 4.24671259 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.02289391 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.98114204 |
| 7 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.87347476 |
| 8 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 3.76050361 |
| 9 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.53547550 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.49408805 |
| 11 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.19250306 |
| 12 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 3.15523194 |
| 13 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.12884788 |
| 14 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 2.98645426 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.96708952 |
| 16 | GATA1_19941826_ChIP-Seq_K562_Human | 2.96643141 |
| 17 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 2.94117016 |
| 18 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.85206454 |
| 19 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.83778773 |
| 20 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.74799388 |
| 21 | SPI1_23127762_ChIP-Seq_K562_Human | 2.74733142 |
| 22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.74249014 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.73296849 |
| 24 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.72862189 |
| 25 | * NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.70687226 |
| 26 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.70225774 |
| 27 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.64745077 |
| 28 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.54415036 |
| 29 | GATA2_19941826_ChIP-Seq_K562_Human | 2.50769937 |
| 30 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.50334850 |
| 31 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.40764904 |
| 32 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 2.39346944 |
| 33 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.37812402 |
| 34 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.37349417 |
| 35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 2.36421116 |
| 36 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 2.36084163 |
| 37 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.36070027 |
| 38 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 2.35996890 |
| 39 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.30930664 |
| 40 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.26800905 |
| 41 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.24757984 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.21301524 |
| 43 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 2.20099486 |
| 44 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 2.17341399 |
| 45 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.15696817 |
| 46 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 2.14396538 |
| 47 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.11779013 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.03429524 |
| 49 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.01500231 |
| 50 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.94172459 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.93473678 |
| 52 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.90460649 |
| 53 | IRF1_19129219_ChIP-ChIP_H3396_Human | 1.87900895 |
| 54 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.77772236 |
| 55 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.77138876 |
| 56 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.75070456 |
| 57 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.71287642 |
| 58 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.70545333 |
| 59 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.66618044 |
| 60 | UTX_26944678_Chip-Seq_JUKART_Human | 1.66609859 |
| 61 | VDR_22108803_ChIP-Seq_LS180_Human | 1.65162816 |
| 62 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.64769143 |
| 63 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.63570904 |
| 64 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.62461775 |
| 65 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.62341251 |
| 66 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.62047269 |
| 67 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.61696617 |
| 68 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.61612072 |
| 69 | GATA1_22025678_ChIP-Seq_K562_Human | 1.61179448 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.61073395 |
| 71 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.60799008 |
| 72 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.59338978 |
| 73 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.58904411 |
| 74 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.58506661 |
| 75 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.58290666 |
| 76 | * MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.57389543 |
| 77 | FUS_26573619_Chip-Seq_HEK293_Human | 1.55295470 |
| 78 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.54231315 |
| 79 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.52168067 |
| 80 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.51980975 |
| 81 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.50910184 |
| 82 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.49160833 |
| 83 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.48842334 |
| 84 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.47836219 |
| 85 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46822305 |
| 86 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.46004674 |
| 87 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.45891587 |
| 88 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.45832848 |
| 89 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.45286628 |
| 90 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.44638519 |
| 91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.44425294 |
| 92 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.44102853 |
| 93 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.41758343 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40477475 |
| 95 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.39832510 |
| 96 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.36861426 |
| 97 | MYB_26560356_Chip-Seq_TH2_Human | 1.36738897 |
| 98 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.32221179 |
| 99 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31805656 |
| 100 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30922183 |
| 101 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.30866817 |
| 102 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.30420627 |
| 103 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.29921956 |
| 104 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.29512238 |
| 105 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.29204233 |
| 106 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.26141777 |
| 107 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.26031392 |
| 108 | NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.24706252 |
| 109 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.24609528 |
| 110 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.23813740 |
| 111 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.23232802 |
| 112 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.22484230 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.21667930 |
| 114 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.20855302 |
| 115 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.20766507 |
| 116 | MAF_26560356_Chip-Seq_TH1_Human | 1.18304113 |
| 117 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.17844919 |
| 118 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.17757708 |
| 119 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 1.17259347 |
| 120 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.16688725 |
| 121 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.16213155 |
| 122 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.14504694 |
| 123 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.14072275 |
| 124 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 1.14015567 |
| 125 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.13700797 |
| 126 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.13507726 |
| 127 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.12244203 |
| 128 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.11826761 |
| 129 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.11624966 |
| 130 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 1.11417887 |
| 131 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.11393698 |
| 132 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.10838935 |
| 133 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10313384 |
| 134 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.10076162 |
| 135 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.09251908 |
| 136 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08971985 |
| 137 | EWS_26573619_Chip-Seq_HEK293_Human | 1.08396180 |
| 138 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.08338328 |
| 139 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07497097 |
| 140 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.06818839 |
| 141 | MYB_26560356_Chip-Seq_TH1_Human | 1.06555684 |
| 142 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.06279318 |
| 143 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.06279318 |
| 144 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.06279318 |
| 145 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.05368325 |
| 146 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.05128407 |
| 147 | TP63_19390658_ChIP-ChIP_HaCaT_Human | 1.04987730 |
| 148 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.04870487 |
| 149 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.04746745 |
| 150 | LMO2_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.03804966 |
| 151 | * TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03725017 |
| 152 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.03080759 |
| 153 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.02779248 |
| 154 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.02418410 |
| 155 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.02167775 |
| 156 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.01291901 |
| 157 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.00728899 |
| 158 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.00441654 |
| 159 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.99470407 |
| 160 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99286031 |
| 161 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99256583 |
| 162 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.98977861 |
| 163 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.98820223 |
| 164 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 0.98620520 |
| 165 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.98309513 |
| 166 | GATA3_26560356_Chip-Seq_TH2_Human | 0.97459794 |
| 167 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.96156007 |
| 168 | MYC_22102868_ChIP-Seq_BL_Human | 0.95696422 |
| 169 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.94480468 |
| 170 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.94460877 |
| 171 | CTCF_18555785_Chip-Seq_ESCs_Mouse | 0.94317007 |
| 172 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.92822153 |
| 173 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.91545835 |
| 174 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.91284242 |
| 175 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.90876629 |
| 176 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.90101495 |
| 177 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.88091462 |
| 178 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87275747 |
| 179 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.87150686 |
| 180 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.86855718 |
| 181 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.86718266 |
| 182 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.86406395 |
| 183 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.84437483 |
| 184 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.83795734 |
| 185 | SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.82478494 |
| 186 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.82321231 |
| 187 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80693759 |
| 188 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.79280223 |
| 189 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 0.77887919 |
| 190 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77771982 |
| 191 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77334378 |
| 192 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.77166799 |
| 193 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 0.76582944 |
| 194 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.75770910 |
| 195 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.75116475 |
| 196 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.72885675 |
| 197 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.72885675 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005464_abnormal_platelet_physiology | 8.88619040 |
| 2 | MP0008004_abnormal_stomach_pH | 4.79230206 |
| 3 | MP0005409_darkened_coat_color | 4.09721212 |
| 4 | MP0003136_yellow_coat_color | 4.00485918 |
| 5 | MP0004381_abnormal_hair_follicle | 3.63866578 |
| 6 | MP0005171_absent_coat_pigmentation | 3.42346059 |
| 7 | MP0000465_gastrointestinal_hemorrhage | 3.38506233 |
| 8 | MP0003303_peritoneal_inflammation | 3.24174526 |
| 9 | MP0001188_hyperpigmentation | 3.23958945 |
| 10 | MP0004510_myositis | 2.79271498 |
| 11 | MP0006292_abnormal_olfactory_placode | 2.73171189 |
| 12 | MP0009379_abnormal_foot_pigmentation | 2.72247293 |
| 13 | MP0000015_abnormal_ear_pigmentation | 2.41057190 |
| 14 | MP0005075_abnormal_melanosome_morpholog | 2.38354694 |
| 15 | MP0001529_abnormal_vocalization | 2.33768135 |
| 16 | MP0005058_abnormal_lysosome_morphology | 2.31846587 |
| 17 | MP0005408_hypopigmentation | 2.27319011 |
| 18 | MP0003436_decreased_susceptibility_to | 2.26284546 |
| 19 | MP0000343_altered_response_to | 2.20514575 |
| 20 | MP0008057_abnormal_DNA_replication | 2.19639677 |
| 21 | MP0005083_abnormal_biliary_tract | 2.19058410 |
| 22 | MP0000566_synostosis | 2.17306625 |
| 23 | MP0001986_abnormal_taste_sensitivity | 2.11783492 |
| 24 | MP0008058_abnormal_DNA_repair | 2.03369298 |
| 25 | MP0002132_abnormal_respiratory_system | 1.98322882 |
| 26 | MP0003880_abnormal_central_pattern | 1.92449659 |
| 27 | MP0010155_abnormal_intestine_physiology | 1.91816966 |
| 28 | MP0003300_gastrointestinal_ulcer | 1.90005090 |
| 29 | MP0003566_abnormal_cell_adhesion | 1.88976205 |
| 30 | MP0003718_maternal_effect | 1.83688344 |
| 31 | MP0000920_abnormal_myelination | 1.81691833 |
| 32 | MP0000372_irregular_coat_pigmentation | 1.74299188 |
| 33 | MP0003941_abnormal_skin_development | 1.72146634 |
| 34 | * MP0002398_abnormal_bone_marrow | 1.69774784 |
| 35 | MP0004947_skin_inflammation | 1.69240378 |
| 36 | MP0003693_abnormal_embryo_hatching | 1.69025844 |
| 37 | MP0001800_abnormal_humoral_immune | 1.68273320 |
| 38 | MP0002723_abnormal_immune_serum | 1.68179502 |
| 39 | MP0001905_abnormal_dopamine_level | 1.67224696 |
| 40 | MP0010094_abnormal_chromosome_stability | 1.66634473 |
| 41 | MP0001545_abnormal_hematopoietic_system | 1.66133922 |
| 42 | MP0005397_hematopoietic_system_phenotyp | 1.66133922 |
| 43 | MP0001851_eye_inflammation | 1.65815666 |
| 44 | MP0009697_abnormal_copulation | 1.62029685 |
| 45 | MP0002419_abnormal_innate_immunity | 1.61002654 |
| 46 | MP0003950_abnormal_plasma_membrane | 1.60870504 |
| 47 | MP0003828_pulmonary_edema | 1.60038403 |
| 48 | MP0002095_abnormal_skin_pigmentation | 1.59696871 |
| 49 | MP0005174_abnormal_tail_pigmentation | 1.59185912 |
| 50 | MP0004742_abnormal_vestibular_system | 1.58448080 |
| 51 | MP0000230_abnormal_systemic_arterial | 1.56860988 |
| 52 | MP0002452_abnormal_antigen_presenting | 1.56071121 |
| 53 | MP0001533_abnormal_skeleton_physiology | 1.55889602 |
| 54 | MP0003111_abnormal_nucleus_morphology | 1.53207705 |
| 55 | MP0005167_abnormal_blood-brain_barrier | 1.52827781 |
| 56 | MP0001790_abnormal_immune_system | 1.52705585 |
| 57 | MP0005387_immune_system_phenotype | 1.52705585 |
| 58 | MP0008789_abnormal_olfactory_epithelium | 1.50703474 |
| 59 | MP0005025_abnormal_response_to | 1.50526108 |
| 60 | MP0002420_abnormal_adaptive_immunity | 1.49774956 |
| 61 | MP0001819_abnormal_immune_cell | 1.47494009 |
| 62 | MP0000685_abnormal_immune_system | 1.47238267 |
| 63 | MP0002638_abnormal_pupillary_reflex | 1.45838504 |
| 64 | MP0002938_white_spotting | 1.45564005 |
| 65 | MP0003638_abnormal_response/metabolism_ | 1.45192458 |
| 66 | MP0005645_abnormal_hypothalamus_physiol | 1.44520902 |
| 67 | MP0009764_decreased_sensitivity_to | 1.42773866 |
| 68 | MP0003879_abnormal_hair_cell | 1.42231691 |
| 69 | MP0002277_abnormal_respiratory_mucosa | 1.40760762 |
| 70 | MP0001663_abnormal_digestive_system | 1.39101143 |
| 71 | MP0000858_altered_metastatic_potential | 1.37901070 |
| 72 | MP0005646_abnormal_pituitary_gland | 1.34734143 |
| 73 | MP0003786_premature_aging | 1.33698084 |
| 74 | MP0008932_abnormal_embryonic_tissue | 1.33369948 |
| 75 | MP0005084_abnormal_gallbladder_morpholo | 1.31202598 |
| 76 | MP0000689_abnormal_spleen_morphology | 1.30863467 |
| 77 | MP0001485_abnormal_pinna_reflex | 1.29150177 |
| 78 | MP0004084_abnormal_cardiac_muscle | 1.28073937 |
| 79 | MP0003866_abnormal_defecation | 1.27712147 |
| 80 | MP0004130_abnormal_muscle_cell | 1.26597480 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.26551915 |
| 82 | MP0001845_abnormal_inflammatory_respons | 1.25987825 |
| 83 | * MP0002429_abnormal_blood_cell | 1.24752806 |
| 84 | MP0008260_abnormal_autophagy | 1.24276645 |
| 85 | MP0001984_abnormal_olfaction | 1.23802085 |
| 86 | MP0001346_abnormal_lacrimal_gland | 1.23784976 |
| 87 | MP0009785_altered_susceptibility_to | 1.22646610 |
| 88 | MP0008007_abnormal_cellular_replicative | 1.22610136 |
| 89 | MP0000249_abnormal_blood_vessel | 1.21872557 |
| 90 | MP0009763_increased_sensitivity_to | 1.20913547 |
| 91 | * MP0000716_abnormal_immune_system | 1.20782678 |
| 92 | MP0004147_increased_porphyrin_level | 1.20585161 |
| 93 | MP0003763_abnormal_thymus_physiology | 1.20117722 |
| 94 | MP0005423_abnormal_somatic_nervous | 1.19185376 |
| 95 | MP0009278_abnormal_bone_marrow | 1.17340858 |
| 96 | MP0001486_abnormal_startle_reflex | 1.17278568 |
| 97 | * MP0002722_abnormal_immune_system | 1.17108537 |
| 98 | MP0008877_abnormal_DNA_methylation | 1.15044296 |
| 99 | MP0005551_abnormal_eye_electrophysiolog | 1.14033606 |
| 100 | MP0002272_abnormal_nervous_system | 1.13999920 |
| 101 | MP0003077_abnormal_cell_cycle | 1.13519212 |
| 102 | MP0003724_increased_susceptibility_to | 1.13431325 |
| 103 | MP0001879_abnormal_lymphatic_vessel | 1.13255423 |
| 104 | MP0001919_abnormal_reproductive_system | 1.13167486 |
| 105 | MP0002998_abnormal_bone_remodeling | 1.13001311 |
| 106 | MP0001186_pigmentation_phenotype | 1.12804340 |
| 107 | MP0002102_abnormal_ear_morphology | 1.11365052 |
| 108 | MP0005671_abnormal_response_to | 1.09359465 |
| 109 | MP0002751_abnormal_autonomic_nervous | 1.09180999 |
| 110 | MP0002148_abnormal_hypersensitivity_rea | 1.08884972 |
| 111 | MP0000762_abnormal_tongue_morphology | 1.08427705 |
| 112 | MP0008872_abnormal_physiological_respon | 1.07983308 |
| 113 | MP0003075_altered_response_to | 1.07085316 |
| 114 | MP0005499_abnormal_olfactory_system | 1.04971754 |
| 115 | MP0005394_taste/olfaction_phenotype | 1.04971754 |
| 116 | MP0004142_abnormal_muscle_tone | 1.04822518 |
| 117 | MP0004036_abnormal_muscle_relaxation | 1.04058407 |
| 118 | MP0005389_reproductive_system_phenotype | 1.04028329 |
| 119 | MP0002405_respiratory_system_inflammati | 1.03386695 |
| 120 | MP0008874_decreased_physiological_sensi | 1.02153023 |
| 121 | MP0000383_abnormal_hair_follicle | 1.01826701 |
| 122 | MP0003656_abnormal_erythrocyte_physiolo | 1.01426566 |
| 123 | MP0000490_abnormal_crypts_of | 0.98795168 |
| 124 | MP0002735_abnormal_chemical_nociception | 0.97575099 |
| 125 | MP0001963_abnormal_hearing_physiology | 0.97158662 |
| 126 | MP0004145_abnormal_muscle_electrophysio | 0.96570318 |
| 127 | MP0009765_abnormal_xenobiotic_induced | 0.94885101 |
| 128 | MP0002736_abnormal_nociception_after | 0.94014226 |
| 129 | MP0000613_abnormal_salivary_gland | 0.92865051 |
| 130 | MP0003938_abnormal_ear_development | 0.92572439 |
| 131 | MP0008775_abnormal_heart_ventricle | 0.92081670 |
| 132 | * MP0000703_abnormal_thymus_morphology | 0.90304846 |
| 133 | MP0009333_abnormal_splenocyte_physiolog | 0.90075461 |
| 134 | MP0006082_CNS_inflammation | 0.88667742 |
| 135 | MP0002733_abnormal_thermal_nociception | 0.87747247 |
| 136 | MP0000026_abnormal_inner_ear | 0.87291697 |
| 137 | MP0005310_abnormal_salivary_gland | 0.84867148 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.84573970 |
| 139 | MP0002163_abnormal_gland_morphology | 0.84521979 |
| 140 | MP0005381_digestive/alimentary_phenotyp | 0.83703186 |
| 141 | MP0010329_abnormal_lipoprotein_level | 0.82539557 |
| 142 | MP0002210_abnormal_sex_determination | 0.82015915 |
| 143 | MP0003453_abnormal_keratinocyte_physiol | 0.79691685 |
| 144 | MP0002752_abnormal_somatic_nervous | 0.79092700 |
| 145 | MP0003172_abnormal_lysosome_physiology | 0.78097287 |
| 146 | MP0005165_increased_susceptibility_to | 0.76445218 |
| 147 | MP0006054_spinal_hemorrhage | 0.76037790 |
| 148 | MP0001968_abnormal_touch/_nociception | 0.75909783 |
| 149 | MP0002075_abnormal_coat/hair_pigmentati | 0.75568584 |
| 150 | MP0005410_abnormal_fertilization | 0.75507800 |
| 151 | MP0002098_abnormal_vibrissa_morphology | 0.74758753 |
| 152 | MP0003315_abnormal_perineum_morphology | 0.74150568 |
| 153 | MP0002160_abnormal_reproductive_system | 0.73621412 |
| 154 | MP0001661_extended_life_span | 0.73486946 |
| 155 | MP0008995_early_reproductive_senescence | 0.72368003 |
| 156 | MP0003195_calcinosis | 0.71990485 |
| 157 | MP0001542_abnormal_bone_strength | 0.70953186 |
| 158 | MP0002877_abnormal_melanocyte_morpholog | 0.70407602 |
| 159 | MP0005253_abnormal_eye_physiology | 0.70146486 |
| 160 | MP0005023_abnormal_wound_healing | 0.68646287 |
| 161 | MP0010386_abnormal_urinary_bladder | 0.67421691 |
| 162 | MP0001835_abnormal_antigen_presentation | 0.67006556 |
| 163 | MP0004883_abnormal_blood_vessel | 0.66813984 |
| 164 | MP0003795_abnormal_bone_structure | 0.66568282 |
| 165 | MP0005666_abnormal_adipose_tissue | 0.65605594 |
| 166 | MP0001765_abnormal_ion_homeostasis | 0.65285104 |
| 167 | MP0005451_abnormal_body_composition | 0.65187511 |
| 168 | MP0005365_abnormal_bile_salt | 0.64703322 |
| 169 | MP0004957_abnormal_blastocyst_morpholog | 0.64511938 |
| 170 | MP0002233_abnormal_nose_morphology | 0.64418896 |
| 171 | MP0000778_abnormal_nervous_system | 0.63559899 |
| 172 | MP0001293_anophthalmia | 0.63409680 |
| 173 | MP0003448_altered_tumor_morphology | 0.62533761 |
| 174 | MP0003183_abnormal_peptide_metabolism | 0.62354792 |
| 175 | MP0001970_abnormal_pain_threshold | 0.62030013 |
| 176 | MP0004808_abnormal_hematopoietic_stem | 0.61835531 |
| 177 | MP0005535_abnormal_body_temperature | 0.61221145 |
| 178 | MP0001502_abnormal_circadian_rhythm | 0.60891517 |
| 179 | MP0002118_abnormal_lipid_homeostasis | 0.60549125 |
| 180 | MP0004782_abnormal_surfactant_physiolog | 0.60151884 |
| 181 | MP0005000_abnormal_immune_tolerance | 0.59989159 |
| 182 | MP0001286_abnormal_eye_development | 0.59985166 |
| 183 | MP0000647_abnormal_sebaceous_gland | 0.59719340 |
| 184 | MP0003937_abnormal_limbs/digits/tail_de | 0.59404000 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormal platelet volume (HP:0011876) | 9.96188157 |
| 2 | Petechiae (HP:0000967) | 9.51460499 |
| 3 | Purpura (HP:0000979) | 9.30631560 |
| 4 | Epistaxis (HP:0000421) | 7.58082428 |
| 5 | Gingival bleeding (HP:0000225) | 6.22648460 |
| 6 | Hyperlipoproteinemia (HP:0010980) | 5.66157544 |
| 7 | Impaired platelet aggregation (HP:0003540) | 5.28567874 |
| 8 | Abnormal platelet function (HP:0011869) | 5.28567874 |
| 9 | Spontaneous hematomas (HP:0007420) | 4.79327077 |
| 10 | Parakeratosis (HP:0001036) | 4.47883470 |
| 11 | Duplicated collecting system (HP:0000081) | 4.30710366 |
| 12 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 4.08224912 |
| 13 | Abnormality of the renal collecting system (HP:0004742) | 3.85403235 |
| 14 | Conjunctival telangiectasia (HP:0000524) | 3.79586378 |
| 15 | Acanthocytosis (HP:0001927) | 3.58859672 |
| 16 | Poikilocytosis (HP:0004447) | 3.52108675 |
| 17 | Abnormality of macrophages (HP:0004311) | 3.51221199 |
| 18 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 3.49859724 |
| 19 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 3.42664451 |
| 20 | 3-Methylglutaconic aciduria (HP:0003535) | 3.36312393 |
| 21 | Dyschromatopsia (HP:0007641) | 3.34838977 |
| 22 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 3.32011876 |
| 23 | Abnormality of lateral ventricle (HP:0030047) | 3.26504232 |
| 24 | Bruising susceptibility (HP:0000978) | 3.17650658 |
| 25 | Stomatitis (HP:0010280) | 3.14349688 |
| 26 | Chromsome breakage (HP:0040012) | 3.13388052 |
| 27 | Renal Fanconi syndrome (HP:0001994) | 3.13235661 |
| 28 | Abnormality of the common coagulation pathway (HP:0010990) | 3.13211374 |
| 29 | Increased density of long bones (HP:0006392) | 3.07318328 |
| 30 | Abnormal pupillary function (HP:0007686) | 2.99364978 |
| 31 | Hepatosplenomegaly (HP:0001433) | 2.97024996 |
| 32 | Cerebral hypomyelination (HP:0006808) | 2.93924300 |
| 33 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 2.93715156 |
| 34 | Eczematoid dermatitis (HP:0000976) | 2.90103473 |
| 35 | Increased IgM level (HP:0003496) | 2.87082574 |
| 36 | Birth length less than 3rd percentile (HP:0003561) | 2.83564895 |
| 37 | Congenital ichthyosiform erythroderma (HP:0007431) | 2.81411123 |
| 38 | Reticulocytopenia (HP:0001896) | 2.80221228 |
| 39 | Paralysis (HP:0003470) | 2.74057673 |
| 40 | Breast hypoplasia (HP:0003187) | 2.71693659 |
| 41 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.71195774 |
| 42 | Obstructive lung disease (HP:0006536) | 2.70175016 |
| 43 | Chronic obstructive pulmonary disease (HP:0006510) | 2.70175016 |
| 44 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.65543863 |
| 45 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.65543863 |
| 46 | Acute necrotizing encephalopathy (HP:0006965) | 2.64280313 |
| 47 | Abnormal number of erythroid precursors (HP:0012131) | 2.61461581 |
| 48 | White forelock (HP:0002211) | 2.56361350 |
| 49 | Increased hepatocellular lipid droplets (HP:0006565) | 2.56144689 |
| 50 | Septo-optic dysplasia (HP:0100842) | 2.54770984 |
| 51 | Hypoplasia of the fovea (HP:0007750) | 2.53920239 |
| 52 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 2.53920239 |
| 53 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.53288785 |
| 54 | Encephalitis (HP:0002383) | 2.52043633 |
| 55 | Patchy hypopigmentation of hair (HP:0011365) | 2.51846761 |
| 56 | Mitochondrial inheritance (HP:0001427) | 2.42731353 |
| 57 | Abnormality of the axillary hair (HP:0100134) | 2.41391953 |
| 58 | Abnormality of secondary sexual hair (HP:0009888) | 2.41391953 |
| 59 | Type I transferrin isoform profile (HP:0003642) | 2.33332858 |
| 60 | Erythroderma (HP:0001019) | 2.33217557 |
| 61 | Xanthomatosis (HP:0000991) | 2.32670429 |
| 62 | Exertional dyspnea (HP:0002875) | 2.32450480 |
| 63 | Abnormality of iron homeostasis (HP:0011031) | 2.31275251 |
| 64 | Conical tooth (HP:0000698) | 2.30943842 |
| 65 | Joint swelling (HP:0001386) | 2.30467867 |
| 66 | Recurrent abscess formation (HP:0002722) | 2.29145409 |
| 67 | Abnormality of the septum pellucidum (HP:0007375) | 2.26727799 |
| 68 | Episodic fever (HP:0001954) | 2.23977409 |
| 69 | Abnormality of renal resorption (HP:0011038) | 2.23318829 |
| 70 | Medial flaring of the eyebrow (HP:0010747) | 2.22520396 |
| 71 | Granulocytopenia (HP:0001913) | 2.20597775 |
| 72 | Eosinophilia (HP:0001880) | 2.19023281 |
| 73 | Aplasia cutis congenita (HP:0001057) | 2.18786463 |
| 74 | Stomach cancer (HP:0012126) | 2.17444957 |
| 75 | Recurrent bacterial skin infections (HP:0005406) | 2.16123502 |
| 76 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.15618257 |
| 77 | Increased serum ferritin (HP:0003281) | 2.15130113 |
| 78 | Aplasia/Hypoplasia involving the musculature (HP:0001460) | 2.14862397 |
| 79 | Absent septum pellucidum (HP:0001331) | 2.14466829 |
| 80 | Joint hemorrhage (HP:0005261) | 2.12223108 |
| 81 | Hyperthyroidism (HP:0000836) | 2.12130062 |
| 82 | Aplasia/hypoplasia of the uterus (HP:0008684) | 2.10500838 |
| 83 | Optic nerve hypoplasia (HP:0000609) | 2.09570666 |
| 84 | Macrocytic anemia (HP:0001972) | 2.08403205 |
| 85 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.07614661 |
| 86 | True hermaphroditism (HP:0010459) | 2.06184393 |
| 87 | Congenital primary aphakia (HP:0007707) | 2.05917281 |
| 88 | Gait imbalance (HP:0002141) | 2.05033746 |
| 89 | Prostate neoplasm (HP:0100787) | 2.03616806 |
| 90 | Ventricular fibrillation (HP:0001663) | 2.02950525 |
| 91 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.02625768 |
| 92 | Increased CSF lactate (HP:0002490) | 2.02459754 |
| 93 | Progressive macrocephaly (HP:0004481) | 2.00860984 |
| 94 | Prolonged bleeding time (HP:0003010) | 11.5539960 |
| 95 | Increased mean platelet volume (HP:0011877) | 10.3303542 |
| 96 | Menorrhagia (HP:0000132) | 10.3260266 |
| 97 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.99597736 |
| 98 | Ureteral duplication (HP:0000073) | 1.99382398 |
| 99 | Nephrogenic diabetes insipidus (HP:0009806) | 1.99076845 |
| 100 | Increased serum lactate (HP:0002151) | 1.98986710 |
| 101 | Dysostosis multiplex (HP:0000943) | 1.98922563 |
| 102 | Autoimmune hemolytic anemia (HP:0001890) | 1.98771782 |
| 103 | Lipid accumulation in hepatocytes (HP:0006561) | 1.98724875 |
| 104 | Abnormal auditory evoked potentials (HP:0006958) | 1.98598081 |
| 105 | Arterial thrombosis (HP:0004420) | 1.97758503 |
| 106 | Polycythemia (HP:0001901) | 1.96943961 |
| 107 | Acute encephalopathy (HP:0006846) | 1.95916296 |
| 108 | Duplication of thumb phalanx (HP:0009942) | 1.95104450 |
| 109 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.94950340 |
| 110 | Congenital sensorineural hearing impairment (HP:0008527) | 1.94697686 |
| 111 | Abnormality of the fovea (HP:0000493) | 1.94590925 |
| 112 | Pancreatic fibrosis (HP:0100732) | 1.94186081 |
| 113 | Upper limb muscle weakness (HP:0003484) | 1.93965070 |
| 114 | Hepatocellular necrosis (HP:0001404) | 1.93259697 |
| 115 | Hypophosphatemic rickets (HP:0004912) | 1.92984933 |
| 116 | Type 2 muscle fiber atrophy (HP:0003554) | 1.92462980 |
| 117 | Congenital stationary night blindness (HP:0007642) | 1.91163406 |
| 118 | Pulmonary artery stenosis (HP:0004415) | 1.90953857 |
| 119 | Optic disc pallor (HP:0000543) | 1.90218867 |
| 120 | Amniotic constriction ring (HP:0009775) | 1.89833147 |
| 121 | Abnormality of placental membranes (HP:0011409) | 1.89833147 |
| 122 | Increased intramyocellular lipid droplets (HP:0012240) | 1.88278781 |
| 123 | Sensory axonal neuropathy (HP:0003390) | 1.87293199 |
| 124 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 1.87161763 |
| 125 | Nausea (HP:0002018) | 1.86633957 |
| 126 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 1.86318332 |
| 127 | Leukocytosis (HP:0001974) | 1.85859396 |
| 128 | Pancreatic cysts (HP:0001737) | 1.85713478 |
| 129 | Decreased central vision (HP:0007663) | 1.85570869 |
| 130 | Generalized aminoaciduria (HP:0002909) | 1.85458861 |
| 131 | Dysautonomia (HP:0002459) | 1.84214299 |
| 132 | Aplasia of the musculature (HP:0100854) | 1.83848830 |
| 133 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.83552926 |
| 134 | Microvesicular hepatic steatosis (HP:0001414) | 1.83384386 |
| 135 | Abnormality of the preputium (HP:0100587) | 1.83257365 |
| 136 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.82848626 |
| 137 | Absent/shortened dynein arms (HP:0200106) | 1.82848626 |
| 138 | Myocardial infarction (HP:0001658) | 1.82129685 |
| 139 | Progressive external ophthalmoplegia (HP:0000590) | 1.81890390 |
| 140 | Basal ganglia calcification (HP:0002135) | 1.81517000 |
| 141 | Abnormality of the ileum (HP:0001549) | 1.81394394 |
| 142 | Retinal dysplasia (HP:0007973) | 1.81042934 |
| 143 | Absent radius (HP:0003974) | 1.80838401 |
| 144 | Male infertility (HP:0003251) | 1.80830588 |
| 145 | Meckel diverticulum (HP:0002245) | 1.80096700 |
| 146 | Long foot (HP:0001833) | 1.78246406 |
| 147 | Tinnitus (HP:0000360) | 1.76726982 |
| 148 | Atelectasis (HP:0100750) | 1.76697312 |
| 149 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.76185470 |
| 150 | Absent forearm bone (HP:0003953) | 1.74613387 |
| 151 | Aplasia involving forearm bones (HP:0009822) | 1.74613387 |
| 152 | Panhypogammaglobulinemia (HP:0003139) | 1.74248833 |
| 153 | Patellar aplasia (HP:0006443) | 1.73465756 |
| 154 | Leukodystrophy (HP:0002415) | 1.72904108 |
| 155 | Absent epiphyses (HP:0010577) | 1.72473730 |
| 156 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.72473730 |
| 157 | Chest pain (HP:0100749) | 1.70270028 |
| 158 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.69621460 |
| 159 | Triphalangeal thumb (HP:0001199) | 1.67614673 |
| 160 | Absent hand (HP:0004050) | 1.67405153 |
| 161 | Abnormality of the prostate (HP:0008775) | 1.67012275 |
| 162 | Abnormality of chromosome stability (HP:0003220) | 1.66928307 |
| 163 | Premature graying of hair (HP:0002216) | 1.66190969 |
| 164 | Exercise intolerance (HP:0003546) | 1.65938231 |
| 165 | Vertigo (HP:0002321) | 1.65342581 |
| 166 | Papillary thyroid carcinoma (HP:0002895) | 1.62619732 |
| 167 | Inflammation of the large intestine (HP:0002037) | 1.62406165 |
| 168 | Recurrent fungal infections (HP:0002841) | 1.60466254 |
| 169 | Abnormality of binocular vision (HP:0011514) | 1.57768690 |
| 170 | Diplopia (HP:0000651) | 1.57768690 |
| 171 | Mucosal telangiectasiae (HP:0100579) | 1.57144285 |
| 172 | Increased IgE level (HP:0003212) | 1.52264998 |
| 173 | Pulmonary embolism (HP:0002204) | 1.52121453 |
| 174 | Distal lower limb amyotrophy (HP:0008944) | 1.52055322 |
| 175 | Increased cerebral lipofuscin (HP:0011813) | 1.51104636 |
| 176 | Thrombophlebitis (HP:0004418) | 1.49076149 |
| 177 | Gastrointestinal inflammation (HP:0004386) | 1.49011446 |
| 178 | Meningitis (HP:0001287) | 1.48124322 |
| 179 | Cerebral ischemia (HP:0002637) | 1.47587318 |
| 180 | T lymphocytopenia (HP:0005403) | 1.46357156 |
| 181 | Hypertriglyceridemia (HP:0002155) | 1.45464717 |
| 182 | Microcytic anemia (HP:0001935) | 1.44858765 |
| 183 | Myositis (HP:0100614) | 1.44803215 |
| 184 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.44474142 |
| 185 | Muscle fibrillation (HP:0010546) | 1.44169224 |
| 186 | Vasculitis (HP:0002633) | 1.43323358 |
| 187 | Optic neuritis (HP:0100653) | 1.41954392 |
| 188 | Retrobulbar optic neuritis (HP:0100654) | 1.41954392 |
| 189 | Hemorrhage of the eye (HP:0011885) | 1.41044423 |
| 190 | Thyroid-stimulating hormone excess (HP:0002925) | 1.40733183 |
| 191 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.40173725 |
| 192 | Hypergammaglobulinemia (HP:0010702) | 1.39478660 |
| 193 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.38220772 |
| 194 | Autoimmune thrombocytopenia (HP:0001973) | 1.37674744 |
| 195 | Orchitis (HP:0100796) | 1.37198045 |
| 196 | Arthralgia (HP:0002829) | 1.35575065 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 5.87568513 |
| 2 | BMX | 3.96406975 |
| 3 | CASK | 3.12467963 |
| 4 | MYLK | 2.89456575 |
| 5 | PBK | 2.88384767 |
| 6 | IRAK3 | 2.58314536 |
| 7 | ZAP70 | 2.49342859 |
| 8 | PLK4 | 2.43885045 |
| 9 | GRK6 | 2.43587948 |
| 10 | SYK | 2.40785741 |
| 11 | PTK2B | 2.37159988 |
| 12 | STK16 | 2.32146461 |
| 13 | ZAK | 2.31036179 |
| 14 | CDK19 | 2.26851332 |
| 15 | SRPK1 | 2.26357981 |
| 16 | BMPR1B | 2.12689088 |
| 17 | FGR | 2.07219401 |
| 18 | CSF1R | 2.06599533 |
| 19 | TAOK3 | 2.05641045 |
| 20 | MST4 | 2.05344085 |
| 21 | GRK5 | 2.04628391 |
| 22 | IRAK4 | 2.01208196 |
| 23 | BUB1 | 1.87650116 |
| 24 | AKT3 | 1.87029520 |
| 25 | MKNK2 | 1.86927892 |
| 26 | EIF2AK1 | 1.86485595 |
| 27 | VRK1 | 1.83601290 |
| 28 | PRPF4B | 1.81895670 |
| 29 | IRAK1 | 1.80587288 |
| 30 | PKN1 | 1.74311794 |
| 31 | TXK | 1.73860509 |
| 32 | MAP2K3 | 1.73331166 |
| 33 | FES | 1.73190742 |
| 34 | ILK | 1.69522046 |
| 35 | HCK | 1.67448537 |
| 36 | STK39 | 1.66587095 |
| 37 | IRAK2 | 1.65117864 |
| 38 | EIF2AK3 | 1.63458323 |
| 39 | MKNK1 | 1.60676709 |
| 40 | TNIK | 1.57797285 |
| 41 | OXSR1 | 1.57368677 |
| 42 | PIK3CG | 1.51927014 |
| 43 | TNK2 | 1.50725351 |
| 44 | NEK6 | 1.42175649 |
| 45 | ADRBK2 | 1.35906428 |
| 46 | PINK1 | 1.35716062 |
| 47 | CSK | 1.34374479 |
| 48 | BMPR2 | 1.34334772 |
| 49 | LYN | 1.34304085 |
| 50 | TAOK1 | 1.33213758 |
| 51 | PIM2 | 1.29214660 |
| 52 | YES1 | 1.28395485 |
| 53 | MAP4K1 | 1.28368753 |
| 54 | TAOK2 | 1.28117194 |
| 55 | BCR | 1.24356544 |
| 56 | WEE1 | 1.23669889 |
| 57 | DAPK3 | 1.21196214 |
| 58 | MAP3K3 | 1.18427643 |
| 59 | MATK | 1.13528076 |
| 60 | EIF2AK2 | 1.13431585 |
| 61 | PAK1 | 1.13391294 |
| 62 | NME2 | 1.07758339 |
| 63 | TSSK6 | 1.07344498 |
| 64 | TRPM7 | 1.05758048 |
| 65 | MAPK13 | 1.05467927 |
| 66 | MAP3K11 | 1.04320150 |
| 67 | MARK3 | 1.02124117 |
| 68 | CLK1 | 1.00759031 |
| 69 | TLK1 | 0.99927792 |
| 70 | ARAF | 0.99637084 |
| 71 | MARK1 | 0.98796715 |
| 72 | MAPKAPK3 | 0.97750871 |
| 73 | NLK | 0.96320757 |
| 74 | STK3 | 0.95655086 |
| 75 | SIK3 | 0.95589846 |
| 76 | ITK | 0.94993214 |
| 77 | LMTK2 | 0.94991676 |
| 78 | BRAF | 0.94951110 |
| 79 | STK24 | 0.94832498 |
| 80 | ACVR1B | 0.94480003 |
| 81 | MAPK15 | 0.94137877 |
| 82 | CCNB1 | 0.91935715 |
| 83 | MAP3K5 | 0.89111773 |
| 84 | DYRK2 | 0.88916339 |
| 85 | PLK3 | 0.88322323 |
| 86 | RPS6KA5 | 0.87047669 |
| 87 | BLK | 0.82121348 |
| 88 | ATR | 0.77437107 |
| 89 | MAP2K7 | 0.77406023 |
| 90 | GRK1 | 0.77027395 |
| 91 | BRSK1 | 0.76869368 |
| 92 | PDK1 | 0.75519890 |
| 93 | EPHB1 | 0.74662459 |
| 94 | MAPK12 | 0.72430312 |
| 95 | CSNK1G3 | 0.72161091 |
| 96 | LCK | 0.71942763 |
| 97 | CDK3 | 0.71284619 |
| 98 | MAPKAPK5 | 0.70639626 |
| 99 | RET | 0.70597155 |
| 100 | ADRBK1 | 0.69348906 |
| 101 | TESK2 | 0.68461315 |
| 102 | MAPK7 | 0.68303357 |
| 103 | CSNK1A1L | 0.67759250 |
| 104 | DAPK2 | 0.65200959 |
| 105 | TTK | 0.64883643 |
| 106 | MUSK | 0.64369291 |
| 107 | NUAK1 | 0.62402545 |
| 108 | PLK1 | 0.61997041 |
| 109 | JAK2 | 0.61796217 |
| 110 | AURKA | 0.61617869 |
| 111 | PDPK1 | 0.61503641 |
| 112 | CAMK2B | 0.59620748 |
| 113 | GRK7 | 0.59060855 |
| 114 | SGK223 | 0.58238573 |
| 115 | SGK494 | 0.58238573 |
| 116 | PRKD1 | 0.57941446 |
| 117 | BTK | 0.57677794 |
| 118 | CAMKK2 | 0.56899667 |
| 119 | EPHA3 | 0.55102037 |
| 120 | JAK3 | 0.54807145 |
| 121 | INSRR | 0.54632149 |
| 122 | MAP3K14 | 0.54390920 |
| 123 | FYN | 0.54212901 |
| 124 | EPHA2 | 0.53645979 |
| 125 | PDGFRB | 0.53401238 |
| 126 | TEC | 0.53332416 |
| 127 | PNCK | 0.53286526 |
| 128 | BRSK2 | 0.50387944 |
| 129 | MAP3K1 | 0.48402514 |
| 130 | PLK2 | 0.48150233 |
| 131 | CSNK1G1 | 0.47704758 |
| 132 | ERBB2 | 0.46818062 |
| 133 | IKBKB | 0.46754630 |
| 134 | JAK1 | 0.46619107 |
| 135 | CDC7 | 0.46565504 |
| 136 | EPHB2 | 0.46134314 |
| 137 | PRKCE | 0.45310385 |
| 138 | CHEK2 | 0.44523615 |
| 139 | HIPK2 | 0.42976072 |
| 140 | CDK7 | 0.42239352 |
| 141 | PIM1 | 0.42222434 |
| 142 | PRKACG | 0.41285049 |
| 143 | CAMK2D | 0.40601917 |
| 144 | STK4 | 0.40212652 |
| 145 | AURKB | 0.39795818 |
| 146 | LIMK1 | 0.38426545 |
| 147 | DAPK1 | 0.37525029 |
| 148 | ROCK2 | 0.37494041 |
| 149 | CSNK2A1 | 0.37381372 |
| 150 | PRKCQ | 0.37099215 |
| 151 | RPS6KB2 | 0.36080764 |
| 152 | MAPK11 | 0.35573136 |
| 153 | PRKD2 | 0.35565540 |
| 154 | RAF1 | 0.34909560 |
| 155 | MAP3K12 | 0.34595525 |
| 156 | BRD4 | 0.34289851 |
| 157 | CHEK1 | 0.33898351 |
| 158 | UHMK1 | 0.33679600 |
| 159 | ATM | 0.32613287 |
| 160 | PRKCD | 0.30401872 |
| 161 | MARK2 | 0.29753115 |
| 162 | CDK14 | 0.29276128 |
| 163 | DYRK1B | 0.29177585 |
| 164 | MAP2K1 | 0.27605932 |
| 165 | PRKG1 | 0.24782223 |
| 166 | PRKCB | 0.23187220 |
| 167 | PKN2 | 0.22784729 |
| 168 | CDC42BPA | 0.22315708 |
| 169 | TYK2 | 0.20056472 |
| 170 | TRIM28 | 0.19921339 |
| 171 | SRC | 0.16798294 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Platelet activation_Homo sapiens_hsa04611 | 4.93203476 |
| 2 | Ribosome_Homo sapiens_hsa03010 | 3.91763488 |
| 3 | RNA polymerase_Homo sapiens_hsa03020 | 3.77137508 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.15153563 |
| 5 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.78276958 |
| 6 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 2.71403428 |
| 7 | DNA replication_Homo sapiens_hsa03030 | 2.43406850 |
| 8 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 2.32347622 |
| 9 | Mismatch repair_Homo sapiens_hsa03430 | 2.25816821 |
| 10 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 2.21217195 |
| 11 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.20163666 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.14868125 |
| 13 | Steroid biosynthesis_Homo sapiens_hsa00100 | 2.14461522 |
| 14 | Parkinsons disease_Homo sapiens_hsa05012 | 2.05977397 |
| 15 | Homologous recombination_Homo sapiens_hsa03440 | 2.05044134 |
| 16 | Spliceosome_Homo sapiens_hsa03040 | 2.04980421 |
| 17 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 2.00016015 |
| 18 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.88538607 |
| 19 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.87018849 |
| 20 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.83933904 |
| 21 | Basal transcription factors_Homo sapiens_hsa03022 | 1.81685608 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.76500978 |
| 23 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.70684886 |
| 24 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.67660075 |
| 25 | Huntingtons disease_Homo sapiens_hsa05016 | 1.67165422 |
| 26 | Purine metabolism_Homo sapiens_hsa00230 | 1.65858603 |
| 27 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.63150836 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.55128712 |
| 29 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.49617164 |
| 30 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.47253215 |
| 31 | Gap junction_Homo sapiens_hsa04540 | 1.47005946 |
| 32 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.46656761 |
| 33 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.44982850 |
| 34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.44694322 |
| 35 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.44279623 |
| 36 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.42823097 |
| 37 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.40520053 |
| 38 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.39664743 |
| 39 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.37229797 |
| 40 | Shigellosis_Homo sapiens_hsa05131 | 1.34607854 |
| 41 | Base excision repair_Homo sapiens_hsa03410 | 1.34161095 |
| 42 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.32498078 |
| 43 | RNA degradation_Homo sapiens_hsa03018 | 1.30530764 |
| 44 | Endocytosis_Homo sapiens_hsa04144 | 1.30036712 |
| 45 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.26093362 |
| 46 | Phototransduction_Homo sapiens_hsa04744 | 1.22964737 |
| 47 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.22525083 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.21428957 |
| 49 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.21378487 |
| 50 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.17739703 |
| 51 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17021476 |
| 52 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.16661484 |
| 53 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.14035993 |
| 54 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.13888554 |
| 55 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.12153662 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.10567434 |
| 57 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.09446459 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.09260857 |
| 59 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.09233699 |
| 60 | Leishmaniasis_Homo sapiens_hsa05140 | 1.07074152 |
| 61 | Cell cycle_Homo sapiens_hsa04110 | 1.06302587 |
| 62 | RNA transport_Homo sapiens_hsa03013 | 1.05263071 |
| 63 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.04272177 |
| 64 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.02612668 |
| 65 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.01938226 |
| 66 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.00636956 |
| 67 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.96741216 |
| 68 | Allograft rejection_Homo sapiens_hsa05330 | 0.95340982 |
| 69 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.94347671 |
| 70 | Tuberculosis_Homo sapiens_hsa05152 | 0.88763901 |
| 71 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.88641123 |
| 72 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.87889128 |
| 73 | Endometrial cancer_Homo sapiens_hsa05213 | 0.85496042 |
| 74 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.85281896 |
| 75 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83784969 |
| 76 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.83377098 |
| 77 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.81099844 |
| 78 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80869840 |
| 79 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.78631512 |
| 80 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.74588840 |
| 81 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.74458820 |
| 82 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.74305469 |
| 83 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.73371875 |
| 84 | Thyroid cancer_Homo sapiens_hsa05216 | 0.73082873 |
| 85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.70779030 |
| 86 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70133659 |
| 87 | Salmonella infection_Homo sapiens_hsa05132 | 0.69363035 |
| 88 | Apoptosis_Homo sapiens_hsa04210 | 0.69264735 |
| 89 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.69003080 |
| 90 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.67675129 |
| 91 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.66974392 |
| 92 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.66770816 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.65314813 |
| 94 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.65078055 |
| 95 | Olfactory transduction_Homo sapiens_hsa04740 | 0.65005954 |
| 96 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.63794425 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.63299686 |
| 98 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63137393 |
| 99 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.62802309 |
| 100 | Sulfur relay system_Homo sapiens_hsa04122 | 0.60855956 |
| 101 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.60744822 |
| 102 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.60649576 |
| 103 | Focal adhesion_Homo sapiens_hsa04510 | 0.60484155 |
| 104 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.60470293 |
| 105 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.59686496 |
| 106 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.59298231 |
| 107 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.58981386 |
| 108 | Metabolic pathways_Homo sapiens_hsa01100 | 0.58643431 |
| 109 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.58236472 |
| 110 | Viral myocarditis_Homo sapiens_hsa05416 | 0.57794219 |
| 111 | Glioma_Homo sapiens_hsa05214 | 0.57345731 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.57305158 |
| 113 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.57213053 |
| 114 | Nicotine addiction_Homo sapiens_hsa05033 | 0.56449068 |
| 115 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.56403543 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55776940 |
| 117 | Histidine metabolism_Homo sapiens_hsa00340 | 0.54584237 |
| 118 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.54008665 |
| 119 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53460446 |
| 120 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52087789 |
| 121 | Legionellosis_Homo sapiens_hsa05134 | 0.51794507 |
| 122 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.51579343 |
| 123 | Amoebiasis_Homo sapiens_hsa05146 | 0.51550226 |
| 124 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.49963049 |
| 125 | Circadian entrainment_Homo sapiens_hsa04713 | 0.47872223 |
| 126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.47009898 |
| 127 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46246973 |
| 128 | Melanoma_Homo sapiens_hsa05218 | 0.45291785 |
| 129 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.45224841 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.45222696 |
| 131 | Asthma_Homo sapiens_hsa05310 | 0.45094399 |
| 132 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.45004123 |
| 133 | Axon guidance_Homo sapiens_hsa04360 | 0.44745860 |
| 134 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.44368429 |
| 135 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.44299086 |
| 136 | Hepatitis B_Homo sapiens_hsa05161 | 0.43716178 |
| 137 | Retinol metabolism_Homo sapiens_hsa00830 | 0.41905778 |
| 138 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.41306206 |
| 139 | Measles_Homo sapiens_hsa05162 | 0.40276347 |
| 140 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.40059551 |
| 141 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.38382987 |
| 142 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.37690244 |
| 143 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.37001957 |
| 144 | Prostate cancer_Homo sapiens_hsa05215 | 0.36938944 |
| 145 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.36836754 |
| 146 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.36225762 |
| 147 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.33657689 |
| 148 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.33385067 |
| 149 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.33272335 |
| 150 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.30636414 |
| 151 | Mineral absorption_Homo sapiens_hsa04978 | 0.29871778 |
| 152 | Alcoholism_Homo sapiens_hsa05034 | 0.29532854 |
| 153 | Morphine addiction_Homo sapiens_hsa05032 | 0.29055653 |
| 154 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.28784193 |
| 155 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.28585797 |
| 156 | Phagosome_Homo sapiens_hsa04145 | 0.26154372 |
| 157 | Taste transduction_Homo sapiens_hsa04742 | 0.25943469 |
| 158 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.25440998 |
| 159 | Malaria_Homo sapiens_hsa05144 | 0.25165011 |
| 160 | Other glycan degradation_Homo sapiens_hsa00511 | 0.24751267 |
| 161 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.23622133 |
| 162 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.22000388 |
| 163 | Pertussis_Homo sapiens_hsa05133 | 0.21680837 |
| 164 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.21326118 |
| 165 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.20061264 |
| 166 | Long-term depression_Homo sapiens_hsa04730 | 0.19704066 |

